Should I buy or sell Tabula Rasa HealthCare stock right now?

4 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Tabula Rasa HealthCare in the last twelve months. There are currently 2 hold ratings and 2 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "moderate buy" TRHC shares. View TRHC analyst ratings or view top-rated stocks .

What is Tabula Rasa HealthCare's stock price target for 2024?

4 Wall Street research analysts have issued 12 month price targets for Tabula Rasa HealthCare's stock. Their TRHC share price targets range from $6.00 to $10.00. On average, they predict the company's share price to reach $8.00 in the next twelve months. This suggests that the stock has a possible downside of 23.8%. View analysts price targets for TRHC or view top-rated stocks among Wall Street analysts .

How have TRHC shares performed in 2023?

Tabula Rasa HealthCare's stock was trading at $4.95 at the start of the year. Since then, TRHC stock has increased by 112.1% and is now trading at $10.50. View the best growth stocks for 2023 here .

How were Tabula Rasa HealthCare's earnings last quarter?

Tabula Rasa HealthCare, Inc. (NASDAQ:TRHC) issued its earnings results on Thursday, November, 4th. The company reported ($0.04) EPS for the quarter, beating analysts' consensus estimates of ($0.19) by $0.15. The company earned $86.60 million during the quarter, compared to analyst estimates of $88.54 million. The company's quarterly revenue was up 22.8% on a year-over-year basis. During the same period in the previous year, the business earned ($0.35) earnings per share.

What is Calvin H. Knowlton, BScPharm, MDiv, PhD's approval rating as Tabula Rasa HealthCare's CEO?

24 employees have rated Tabula Rasa HealthCare Chief Executive Officer Calvin H. Knowlton, BScPharm, MDiv, PhD on Glassdoor.com . Calvin H. Knowlton, BScPharm, MDiv, PhD has an approval rating of 91% among the company's employees. This puts Calvin H. Knowlton, BScPharm, MDiv, PhD in the top 30% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of Tabula Rasa HealthCare own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Tabula Rasa HealthCare investors own include NVIDIA (NVDA) , Advanced Micro Devices (AMD) , QUALCOMM (QCOM) , Adobe (ADBE) , Micron Technology (MU) , Boeing (BA) , Salesforce (CRM) , Intel (INTC) and Netflix (NFLX) .

When did Tabula Rasa HealthCare IPO?

(TRHC) raised $60 million in an initial public offering on Thursday, September 29th 2016. The company issued 4,300,000 shares at $13.00-$15.00 per share. Wells Fargo Securities, UBS Investment Bank and Piper Jaffray served as the underwriters for the IPO and Baird and Stifel were co-managers.

Who are Tabula Rasa HealthCare's major shareholders?

Tabula Rasa HealthCare's stock is owned by a number of retail and institutional investors. Top institutional investors include Beryl Capital Management LLC (2.19%), Qube Research & Technologies Ltd (1.36%), Gabelli Funds LLC (1.31%), Kennedy Capital Management LLC (1.11%), GABELLI & Co INVESTMENT ADVISERS INC. (0.91%) and EHP Funds Inc. (0.83%). Insiders that own company stock include Andrea Carolan Speers , Brian W Adams , Calvin H Knowlton , Dennis Helling , Gordon Tunstall , Indaba Capital Management, LP, Jan Berger , Michael Greenhalgh , Michael J Purcell, Orsula V Knowlton, Orsula V Knowlton , Samira Beckwith and Thomas Cancro. View institutional ownership trends .

How do I buy shares of Tabula Rasa HealthCare?

Shares of TRHC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull , Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here .

Tabula Rasa HealthCare Stock Price, News & Analysis (NASDAQ:TRHC)

$10.50

+0.09 (+0.86%)

(As of 11/3/2023)

Compare

Today's Range: $10.41
▼
$10.50
50-Day Range: $10.30
▼
$10.50
52-Week Range: $3.15
▼
$10.50

Volume: 1.31 million shs
Average Volume: 225,500 shs
Market Capitalization: $284.13 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: $8.00

Tabula Rasa HealthCare MarketRank™ Stock Analysis

Analyst Rating: Moderate Buy
2.50 Rating Score
Upside/Downside: 23.8% Downside
$8.00 Price Target
Short Interest: N/A
Dividend Strength: N/A
Sustainability: N/A
News Sentiment: N/A
Insider Trading: N/A
Proj. Earnings Growth: Growing
From ($0.54) to ($0.35) Per Share

Overall MarketRank^™

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.11 out of 5 stars

Medical Sector

932nd out of 951 stocks

Health Information Services Industry

5th out of 5 stocks

1.3

Analyst's Opinion

Consensus Rating
Tabula Rasa HealthCare has received a consensus rating of Moderate Buy. The company's average rating score is 2.50, and is based on 2 buy ratings, 2 hold ratings, and no sell ratings.
Price Target Upside/Downside
According to analysts' consensus price target of $8.00, Tabula Rasa HealthCare has a forecasted downside of 23.8% from its current price of $10.50.
Amount of Analyst Coverage
Tabula Rasa HealthCare has received no research coverage in the past 90 days.

N/A

Short Interest

Short Interest
There is no current short interest data available for TRHC.

0.0

Dividend Strength

Dividend Yield
Tabula Rasa HealthCare does not currently pay a dividend.
Dividend Growth
Tabula Rasa HealthCare does not have a long track record of dividend growth.

N/A

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score
There is no current Upright™ data available for TRHC.

0.6

News and Social Media Coverage

News Coverage This Week
MarketBeat has tracked 1 news article for Tabula Rasa HealthCare this week, compared to 1 article on an average week.
Search Interest
1 people have searched for TRHC on MarketBeat in the last 30 days.
MarketBeat Follows
Only 4 people have added Tabula Rasa HealthCare to their MarketBeat watchlist in the last 30 days. This is a decrease of -50% compared to the previous 30 days.

3.3

Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Tabula Rasa HealthCare insiders have not sold or bought any company stock.
Percentage Held by Insiders
30.30% of the stock of Tabula Rasa HealthCare is held by insiders. A high percentage of insider ownership can be a sign of company health.
Percentage Held by Institutions
61.88% of the stock of Tabula Rasa HealthCare is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

0.6

Earnings and Valuation

Earnings Growth
Earnings for Tabula Rasa HealthCare are expected to grow in the coming year, from ($0.54) to ($0.35) per share.
Price to Earnings Ratio vs. the Market
The P/E ratio of Tabula Rasa HealthCare is -2.73, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Earnings Ratio vs. Sector
The P/E ratio of Tabula Rasa HealthCare is -2.73, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

See Top Rated MarketRank™ Stocks Here

About Tabula Rasa HealthCare Stock (NASDAQ:TRHC)

Tabula Rasa HealthCare, Inc. operates as a healthcare technology company in the United States. The company operates in two segments, CareVention HealthCare and MedWise HealthCare. It offers EireneRx, a cloud-based medication decision-support and e-prescribing platform to access patient medication-related information; and MedWise Risk Score, a medication risk stratification technology for identification of patients in need of clinical intervention. The company also provides TruChart that offers electronic health records (EHR), care coordination, and financial management in one program allowing Programs of All-Inclusive Care for the Elderly (PACE) to track measurable outcomes in defined timeframes for the populations they serve; and PACElogic, which delivers sharable workflows comprising EHR, customer relationship management, claims adjudication, electronic data interchange, care management, coordination and planning, integration with community-based providers, and various federal and state that requires reporting. In addition, it provides clinical pharmacist collaboration, prescription fulfillment and adherence packaging, and pharmacy benefit management services, as well as health plan management services, including risk adjustment and third-party administrator services. As of December 31, 2022, it served approximately 150 healthcare organizations. The company provides cloud-based software applications to assist prescribers and pharmacists. Tabula Rasa HealthCare, Inc. was founded in 2009 and is headquartered in Moorestown, New Jersey. As of November 3, 2023, Tabula Rasa HealthCare, Inc. operates as a subsidiary of Exact Care Pharmacy, LLC.

TRHC Stock Price History

30 days | 90 days | 365 days | Advanced Chart

TRHC Stock News Headlines

November 29, 2023 | americanbankingnews.com

Tabula Rasa HealthCare (NASDAQ:TRHC) Now Covered by StockNews.com

November 22, 2023 | americanbankingnews.com

Tabula Rasa HealthCare (NASDAQ:TRHC) & Forian (NASDAQ:FORA) Critical Contrast

December 2, 2023 | DTI Trader (Ad)

All the trading advice you’ve ever received boils down to this

All the trading advice you’ve ever received boils down to one goal and one goal only: finding a reliable edge in the markets. If you can do that, grab hold of it and never let go. Because once you have that edge, and you can count on it, you never need to do anything else.

October 31, 2023 | msn.com

Tabula Rasa HealthCare gets stockholder nod for going-private transaction

October 31, 2023 | finance.yahoo.com

Tabula Rasa HealthCare Stockholders Approve Acquisition by Nautic Partners

September 20, 2023 | finance.yahoo.com

With 46% ownership, Tabula Rasa HealthCare, Inc. (NASDAQ:TRHC) has piqued the interest of institutional investors

September 6, 2023 | thestreet.com

Tabula Rasa HealthCare Inc. News

August 31, 2023 | msn.com

Tabula Rasa HealthCare (TRHC) Price Target Increased by 23.38% to 10.54

December 2, 2023 | DTI Trader (Ad)

All the trading advice you’ve ever received boils down to this

August 8, 2023 | markets.businessinsider.com

Stifel Nicolaus Sticks to Their Hold Rating for Tabula Rasa HealthCare (TRHC)

August 8, 2023 | msn.com

William Blair Downgrades Tabula Rasa HealthCare (TRHC)

August 8, 2023 | markets.businessinsider.com

Piper Sandler Reaffirms Their Hold Rating on Tabula Rasa HealthCare (TRHC)

August 8, 2023 | markets.businessinsider.com

Why Are Tabula Rasa HealthCare Shares Moving Higher Today?

August 8, 2023 | finance.yahoo.com

Tabula Rasa Healthcare (TRHC) Q2 Earnings and Revenues Surpass Estimates

August 8, 2023 | finance.yahoo.com

Compared to Estimates, Tabula Rasa Healthcare (TRHC) Q2 Earnings: A Look at Key Metrics

August 8, 2023 | finance.yahoo.com

Tabula Rasa agrees to be acquired in $570M all-cash deal, less than a year after pushing out its founder

August 8, 2023 | finance.yahoo.com

Why Shares of Tabula Rasa HealthCare Are Soaring Monday

August 7, 2023 | finanznachrichten.de

Tabula Rasa HealthCare, Inc.: Tabula Rasa HealthCare Reports Second Quarter 2023 Financial Results

August 7, 2023 | seekingalpha.com

Tabula Rasa going private; will merge with ExactCare Pharmacy

August 7, 2023 | marketwatch.com

Tabula Rasa Shares Rally Premarket on Private-Equity Buyout

August 7, 2023 | markets.businessinsider.com

Tabula Rasa To Go Private In $570 Mln Deal With Nautic Partners; Stock Up In Premarket

August 7, 2023 | marketwatch.com

Nautic Partners to Buy Tabula Rasa HealthCare in $570 Million Deal >TRHC

August 7, 2023 | finance.yahoo.com

Tabula Rasa and ExactCare to Combine to Create a Leading, Independent Pharmacy Care Management Company That Services Patients with the Most Complex Needs

August 7, 2023 | finance.yahoo.com

Tabula Rasa HealthCare Reports Second Quarter 2023 Financial Results

August 4, 2023 | benzinga.com

Earnings Outlook For Tabula Rasa HealthCare

July 25, 2023 | finance.yahoo.com

Tabula Rasa HealthCare Schedules Second Quarter 2023 Earnings Conference Call

June 12, 2023 | finance.yahoo.com

Tabula Rasa Healthcare (TRHC) Surges 7.8%: Is This an Indication of Further Gains?

See More Headlines

Receive TRHC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Tabula Rasa HealthCare and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings: 11/04/2021
Today: 12/02/2023
Fiscal Year End: 12/31/2023

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Health Information Services
Sub-Industry: N/A
Sector: Medical
Current Symbol: NASDAQ:TRHC
CUSIP: N/A
CIK: 1651561
Web: www.tabularasahealthcare.com
Phone: (866) 648-2767
Fax: N/A
Employees: 1,027
Year Founded: N/A

Price Target and Rating

Average Stock Price Target: $8.00
High Stock Price Target: $10.00
Low Stock Price Target: $6.00
Potential Upside/Downside: -23.8%
Consensus Rating: Moderate Buy
Rating Score (0-4): 2.50
Research Coverage: 4 Analysts

Profitability

EPS (Most Recent Fiscal Year): ($3.85)
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: $-147,510,000.00
Net Margins: -28.23%
Pretax Margin: -17.99%
Return on Equity: N/A
Return on Assets: -8.80%

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: 1.57
Quick Ratio: 1.47

Sales & Book Value

Annual Sales: $299.52 million
Price / Sales: 0.95
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: ($2.10) per share
Price / Book: -5.00

Miscellaneous

Outstanding Shares: 27,060,000
Free Float: 18,857,000
Market Cap: $284.13 million
Optionable: Optionable
Beta: 1.57

The Best High-Yield Dividend Stocks for 2023

Looking to generate income with your stock portfolio? Use these ten stocks to generate a safe and reliable source of investment income.

Get This Free Report

Key Executives

Mr. Brian W. Adams (Age 41)
CEO, President & Director
Comp: $668.21k
Mr. Thomas J. Cancro C.F.A. (Age 55)
CPA, Chief Financial Officer
Comp: $523.42k
Mr. Michael Greenhalgh BScPharm (Age 61)
RPh, COO & President of Pharmacy Services
Comp: $630.9k
Mr. Michael Bruno (Age 35)
VP, Corporate Controller & Chief Accounting Officer
Mr. Bob Sullivan M.S.
Chief Technology Officer
Mr. Phillip W. Heath MS (Age 57)
Chief Administrative Officer
Mr. Frank Sparacino C.F.A.
CPA, Senior Vice President of Investor Relations & Corporate Development
Mr. Richard W. Rew II (Age 55)
Chief Legal Officer & Corporate Secretary
Ms. Kathleen D Larkin M.B.A.
Chief People Officer
Ms. Andrea Carolan Speers M.S. (Age 42)
Chief of Staff

Key Competitors

View All Competitors

Insiders & Institutions

View All Insider Transactions
View All Institutional Transactions

TRHC Stock Analysis - Frequently Asked Questions

Should I buy or sell Tabula Rasa HealthCare stock right now?: 4 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Tabula Rasa HealthCare in the last twelve months. There are currently 2 hold ratings and 2 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "moderate buy" TRHC shares.
View TRHC analyst ratings or view top-rated stocks.
What is Tabula Rasa HealthCare's stock price target for 2024?: 4 Wall Street research analysts have issued 12 month price targets for Tabula Rasa HealthCare's stock. Their TRHC share price targets range from $6.00 to $10.00. On average, they predict the company's share price to reach $8.00 in the next twelve months. This suggests that the stock has a possible downside of 23.8%.
View analysts price targets for TRHC or view top-rated stocks among Wall Street analysts.
How have TRHC shares performed in 2023?: Tabula Rasa HealthCare's stock was trading at $4.95 at the start of the year. Since then, TRHC stock has increased by 112.1% and is now trading at $10.50.
View the best growth stocks for 2023 here.
How were Tabula Rasa HealthCare's earnings last quarter?: Tabula Rasa HealthCare, Inc. (NASDAQ:TRHC) issued its earnings results on Thursday, November, 4th. The company reported ($0.04) EPS for the quarter, beating analysts' consensus estimates of ($0.19) by $0.15. The company earned $86.60 million during the quarter, compared to analyst estimates of $88.54 million. The company's quarterly revenue was up 22.8% on a year-over-year basis. During the same period in the previous year, the business earned ($0.35) earnings per share.
What is Calvin H. Knowlton, BScPharm, MDiv, PhD's approval rating as Tabula Rasa HealthCare's CEO?: 24 employees have rated Tabula Rasa HealthCare Chief Executive Officer Calvin H. Knowlton, BScPharm, MDiv, PhD on Glassdoor.com. Calvin H. Knowlton, BScPharm, MDiv, PhD has an approval rating of 91% among the company's employees. This puts Calvin H. Knowlton, BScPharm, MDiv, PhD in the top 30% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of Tabula Rasa HealthCare own?: Based on aggregate information from My MarketBeat watchlists, some companies that other Tabula Rasa HealthCare investors own include NVIDIA (NVDA), Advanced Micro Devices (AMD), QUALCOMM (QCOM), Adobe (ADBE), Micron Technology (MU), Boeing (BA), Salesforce (CRM), Intel (INTC) and Netflix (NFLX).
When did Tabula Rasa HealthCare IPO?: (TRHC) raised $60 million in an initial public offering on Thursday, September 29th 2016. The company issued 4,300,000 shares at $13.00-$15.00 per share. Wells Fargo Securities, UBS Investment Bank and Piper Jaffray served as the underwriters for the IPO and Baird and Stifel were co-managers.
Who are Tabula Rasa HealthCare's major shareholders?: Tabula Rasa HealthCare's stock is owned by a number of retail and institutional investors. Top institutional investors include Beryl Capital Management LLC (2.19%), Qube Research & Technologies Ltd (1.36%), Gabelli Funds LLC (1.31%), Kennedy Capital Management LLC (1.11%), GABELLI & Co INVESTMENT ADVISERS INC. (0.91%) and EHP Funds Inc. (0.83%). Insiders that own company stock include Andrea Carolan Speers, Brian W Adams, Calvin H Knowlton, Dennis Helling, Gordon Tunstall, Indaba Capital Management, LP, Jan Berger, Michael Greenhalgh, Michael J Purcell, Orsula V Knowlton, Orsula V Knowlton, Samira Beckwith and Thomas Cancro.
View institutional ownership trends.
How do I buy shares of Tabula Rasa HealthCare?: Shares of TRHC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

This page (NASDAQ:TRHC) was last updated on 12/2/2023 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Tabula Rasa HealthCare Stock Price, News & Analysis (NASDAQ:TRHC)

Tabula Rasa HealthCare MarketRank™ Stock Analysis

Overall MarketRank™

Analyst's Opinion

Short Interest

Short Interest

Dividend Strength

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score

News and Social Media Coverage

News Coverage This Week

Search Interest

MarketBeat Follows

Company Ownership

Earnings and Valuation

About Tabula Rasa HealthCare Stock (NASDAQ:TRHC)

TRHC Stock Price History

TRHC Stock News Headlines

Company Calendar

Industry, Sector and Symbol

Price Target and Rating

Profitability

Debt

Sales & Book Value

Miscellaneous

Key Executives

Key Competitors

Insiders & Institutions

TRHC Stock Analysis - Frequently Asked Questions

Overall MarketRank^™